Supplementary Figure S3 p-Src t-Src t-AKT p-AKT p-p70S6K t-p70S6K p-S6 t-S6 β-actin p-Fox01/3a DMSO Rap 0 1 2 3 4 p:t-AKT DMSO Rap 0 1 2 3 4 DMS O Das Rap Com bo DM S O Das Rap Com bo 1hr 24hr MCF7 0 2 4 6 0 2 4 6 DMS O Das Rap Combo DMS O Das Rap Combo 1hr 24hr MDA-MB-231 0 1 2 3 0 1 2 3 DMSO Das Rap Com bo DMSO Das Rap Combo 1hr 24hr BT474 Analysis of mTOR and AKT signaling in breast cancer cell lines treated with dasatinib and rapamycin
Supplementary Figure S3
Feb 23, 2016
Supplementary Figure S3. Analysis of mTOR and AKT signaling in breast cancer cell lines treated with dasatinib and rapamycin. MCF7. MDA-MB-231. BT474. 1hr. 24hr. 1hr. 24hr. 1hr. 24hr. Combo. Combo. Combo. Combo. Combo. Combo. DMSO. DMSO. DMSO. DMSO. DMSO. DMSO. Rap. - PowerPoint PPT Presentation
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Supplementary Figure S3
p-Src
t-Src
t-AKT
p-AKT
p-p70S6K
t-p70S6K
p-S6
t-S6
β-actin
p-Fox01/3a
DMSO Das Rap
Combo01234
p:t-
AKT
DMSO Das Rap
Combo01234
DMSO
Das Rap
Com
bo
DMSO
Das Rap
Com
bo
1hr 24hr
MCF7
DMSO Das Rap
Combo0123456
DMSO Das Rap
Combo0123456
DMSO
Das Rap
Com
bo
DMSO
Das Rap
Com
bo
1hr 24hr
MDA-MB-231
DMSO Das Rap
Combo0
0.51
1.52
2.53
DMSO Das Rap
Combo0
1
2
3
DMSO
Das Rap
Combo
DMSO
Das Rap
Combo
1hr 24hr
BT474
Analysis of mTOR and AKT signaling in breast cancer cell lines treated with dasatinib and rapamycin
Related Documents
